This compound is a chiral pharmaceutical intermediate featuring a complex cyclopenta-dioxolane core structure with an ethyl ester and a benzyloxycarbonyl-protected amine group. It is used in the synthesis of active pharmaceutical ingredients.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 866551-95-3
Phenylmethyl N-[(3aS,4R,6S,6aR)-tetrahydro-6-(2-hydroxyethoxy)-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]carbamate
Pharmaceutical intermediate synthesis
(S)-1-(3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)-N-methylmethanamine
Ivabradine hydrochloride impurity D
2,2,2-trifluoro-1-(piperidin-4-yl)ethan-1-one
Pharmaceutical intermediate
Triethyl phosphonoacetate
Horner-Wadsworth-Emmons reaction reagent
S-Methylisothiourea hemisulfate
pharmaceutical intermediate
Carbamic acid, N-((3aS,4R,6S,6aR)-tetrahydro-6-hydroxy-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl)-, phenylmethyl ester
Pharmaceutical intermediate with acetal and carbamate groups
ethyl 2-[[(3aR,4S,6R,6aS)-2,2-dimethyl-6-(phenylmethoxycarbonylamino)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]acetate
LMOJGNUNTMQCBQ-MXSMSXNCSA-N
CCOC(=O)CO[C@H]1C[C@H]([C@H]2[C@@H]1OC(O2)(C)C)NC(=O)OCC3=CC=CC=C3
—